|Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence|
G Genovese, AK Kähler, RE Handsaker, J Lindberg, SA Rose, ...
New England Journal of Medicine 371 (26), 2477-2487, 2014
|Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry|
G Juliusson, P Antunovic, Å Derolf, S Lehmann, L Möllgård, ...
Blood 113 (18), 4179-4187, 2009
|Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population.|
H Bower, M Björkholm, PW Dickman, M Höglund, PC Lambert, ...
University of Leicester, 2016
|Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemia|
K Porkka, P Koskenvesa, T Lundán, J Rimpiläinen, S Mustjoki, R Smykla, ...
Blood 112 (4), 1005-1012, 2008
|Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy|
S Mustjoki, M Ekblom, TP Arstila, I Dybedal, PK Epling-Burnette, F Guilhot, ...
Leukemia 23 (8), 1398-1405, 2009
|Acute myeloid leukemia in the real world: why population-based registries are needed|
G Juliusson, V Lazarevic, AS Hörstedt, O Hagberg, M Höglund
Blood 119 (17), 3890-3899, 2012
|Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry|
S Lehmann, A Ravn, L Carlsson, P Antunovic, S Deneberg, L Möllgård, ...
Leukemia 25 (7), 1128-1134, 2011
|Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008|
M Björkholm, L Ohm, S Eloranta, Å Derolf, M Hultcrantz, J Sjöberg, ...
Journal of Clinical Oncology 29 (18), 2514, 2011
|Sex differences in fertility-related information received by young adult cancer survivors|
GM Armuand, KA Rodriguez-Wallberg, L Wettergren, J Ahlgren, G Enblad, ...
Journal of Clinical Oncology 30 (17), 2147-2153, 2012
|Epidemiology of chronic myeloid leukaemia: an update|
M Höglund, F Sandin, B Simonsson
Annals of hematology 94 (2), 241-247, 2015
|Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)—what is the difference?|
Medical oncology 15 (4), 229-233, 1998
|Characterization and prognostic features of secondary acute myeloid leukemia in a population‐based setting: A report from the S wedish A cute L eukemia R egistry|
E Hulegårdh, C Nilsson, V Lazarevic, H Garelius, P Antunovic, ...
American journal of hematology 90 (3), 208-214, 2015
|Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia|
M Ilander, U Olsson-Strömberg, H Schlums, J Guilhot, O Brück, ...
Leukemia 31 (5), 1108-1116, 2017
|Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry|
M Höglund, F Sandin, K Hellström, M Björeman, M Björkholm, M Brune, ...
Blood, The Journal of the American Society of Hematology 122 (7), 1284-1292, 2013
S Lehmann, S Deneberg, P Antunovic, Å Rangert-Derolf, H Garelius, ...
Leukemia 20, 42-47, 2006
|Mobilization of CD34+ cells by glycosylated and nonglycosylated G‐CSF in healthy volunteers—a comparative study|
M Höglund, B Smedmyr, M Bengtsson, TH Tötterman, ...
European journal of haematology 59 (3), 177-183, 1997
|Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations|
V Ljungström, D Cortese, E Young, T Pandzic, L Mansouri, K Plevova, ...
Blood, The Journal of the American Society of Hematology 127 (8), 1007-1016, 2016
|Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.|
M Höglund, B Smedmyr, B Simonsson, T Tötterman, M Bengtsson
Bone marrow transplantation 18 (1), 19-27, 1996
|Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival|
G Juliusson, R Billström, A Gruber, E Hellström-Lindberg, M Höglund, ...
Leukemia 20 (1), 42-47, 2006
|Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant …|
Y Qu, A Lennartsson, VI Gaidzik, S Deneberg, M Karimi, S Bengtzén, ...
Epigenetics 9 (8), 1108-1119, 2014